- Home
- ARQT vs AVNS Comparison
ARQT vs AVNS Comparison
Compare ARQT & AVNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARQT
- AVNS
- Stock Information
- Founded
- ARQT 2016
- AVNS 2014
- Country
- ARQT United States
- AVNS United States
- Employees
- ARQT N/A
- AVNS N/A
- Industry
- ARQT Biotechnology: Pharmaceutical Preparations
- AVNS Industrial Specialties
- Sector
- ARQT Health Care
- AVNS Health Care
- Exchange
- ARQT Nasdaq
- AVNS Nasdaq
- Market Cap
- ARQT 1.1B
- AVNS 938.0M
- IPO Year
- ARQT 2020
- AVNS N/A
- Fundamental
- Price
- ARQT $14.99
- AVNS $16.10
- Analyst Decision
- ARQT Strong Buy
- AVNS Hold
- Analyst Count
- ARQT 4
- AVNS 1
- Target Price
- ARQT $15.50
- AVNS N/A
- AVG Volume (30 Days)
- ARQT 2.2M
- AVNS 369.2K
- Earning Date
- ARQT 11-06-2024
- AVNS 02-18-2025
- Dividend Yield
- ARQT N/A
- AVNS N/A
- EPS Growth
- ARQT N/A
- AVNS N/A
- EPS
- ARQT N/A
- AVNS 0.34
- Revenue
- ARQT $138,708,000.00
- AVNS $681,500,000.00
- Revenue This Year
- ARQT $208.32
- AVNS $3.84
- Revenue Next Year
- ARQT $48.56
- AVNS $4.37
- P/E Ratio
- ARQT N/A
- AVNS $34.14
- Revenue Growth
- ARQT 182.84
- AVNS N/A
- 52 Week Low
- ARQT $2.60
- AVNS $16.02
- 52 Week High
- ARQT $15.77
- AVNS $25.36
- Technical
- Relative Strength Index (RSI)
- ARQT 67.53
- AVNS 26.40
- Support Level
- ARQT $12.66
- AVNS $16.02
- Resistance Level
- ARQT $15.02
- AVNS $18.91
- Average True Range (ATR)
- ARQT 1.11
- AVNS 0.60
- MACD
- ARQT 0.14
- AVNS -0.19
- Stochastic Oscillator
- ARQT 78.92
- AVNS 2.32
About ARQT Arcutis Biotherapeutics Inc.
Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's lead product candidate ZORYVE roflumilast cream, has successfully completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population.
About AVNS Avanos Medical Inc.
Avanos Medical Inc is a United States-based company that develops and sells medical devices and related services globally. Its operating and reportable segment provides medical device products to healthcare providers and patients. The company has now changed two franchises: has combined Chronic Care and Pain Management franchises into a single commercial organization focused on the Digestive Health and Pain Management and Recovery product categories that generate its revenue from its Chronic Care franchise and in North America.